A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy Adults
Clinical trial NCT05470400 · TERMINATED
Trial details
- NCT number
- NCT05470400
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-15
- Primary completion
- 2024-01-24
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.